StemCellPatents.com Newsletter

Hello manoj kumar valluru,

An interesting patent, # 7,459,307, was issued last week covering the use of cord blood stem cells together with biodegradable scaffolds for treatment of cartilage injury.  Vet-Stem has created a profitable business through using autologous fat for treatment of similar conditions.  This will be an interesting area to watch, especially for high-performance athletes.

Another patent, #7,462,602, covers the use of ribozymes for inhibition of scar tissue formation.  The ribozymes target connective tissue growth factor (CTGF).

In the news, the first time in the world, autologous stem cells were administered via the intracoronary route to a 2-year old patient with heart failure caused by dilated cardiomyopathy. 

 

Composition for treatment of articular cartilage damage     Patent Number: 7,459,307 Assignee | Inventor Cord blood derived stem cells represent a potent source of young, pluripotent, cells.  Although previously their use was restricted to hematological malignancies, newer studies have demonstrated cord blood cells may be useful for many regenerative purposes, such as Ethicon's patent #7,413,734 which teaches...[Read More] Ask a question OR leave your comments.

Cardiac Stem Cell Therapy in 2 Year Old Monday December 15th, 2008 @ 22:09:43 EST Giessen, Germany - Adult stem cell therapy has previously been used for heart failure, primarily in acute post-infarct situations.  In a very interesting paper (Rupp et al. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy...[Read More] Ask a question OR leave your comments. Read more StemCellPatents.com News

The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)

RECENTLY ADDED PATENTS     Mammary stem cell marker (7,563,619) Assignee | Inventor | Ask a question OR leave your comments     Soft tissue repair and regeneration using postpartum-derived cells (7,560,276) Assignee | Inventor | Ask a question OR leave your comments     Compositions and methods for generating skin (7,560,275) Assignee | Inventor | Ask a question OR leave your comments     Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease (7,560,102) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,560,280) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,556,801) Assignee | Inventor | Ask a question OR leave your comments     Dedifferentiated, programmable stem cells of monocytic origin, and their production and use (7,553,663) Assignee | Inventor | Ask a question OR leave your comments     Stromal antigen-presenting cells and use thereof (7,553,661) Assignee | Inventor | Ask a question OR leave your comments     Directed in vitro differentiation of marrow stromal cells into neural cell progenitors (7,547,545) Assignee | Inventor | Ask a question OR leave your comments     Progenitor cells from wharton's jelly of human umbilical cord (7,547,546) Assignee | Inventor | Ask a question OR leave your comments     View all 1436 Stem Cell Patents on StemCellPatents.com

LATEST NEWS     Leptin Blocks T Regulatory Cell Expansion August 23rd, 2009     Mechanism of Multiple Sclerosis Stem Cell Therapy July 24th, 2009 : 2 Comments     Lithium for Treatment of Multiple Sclerosis July 15th, 2009     Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells July 9th, 2009 : 2 Comments     Apoptotic Cells Secrete Angiogenic Factors June 27th, 2009     Read more news on StemCellPatents.com

LATEST JOBS POSTS     View the StemCellPatents.com Job Board

Thanks again for your help in supporting StemCellPatents.com.

We welcome your comments and suggestions! Tell us here.

Media Partnerships (NEW)

(BETA)